Published • loading... • Updated
Small GLP-1 Studies Show Promise for PMOS Treatment
Early trial data showed 8 of 11 participants lost at least 10% of body weight, while testosterone, blood sugar and insulin levels also fell.
- Small but growing research shows GLP-1 obesity medications may treat polyendocrine metabolic ovarian syndrome by promoting weight loss and improving insulin resistance, hormone balance and ovulation.
- PMOS, renamed earlier this year to shift focus away from ovaries and cysts, affects 1 in 8 women worldwide; diagnosis often takes years because symptoms overlap with other conditions and vary widely.
- Dr. Melanie Cree, who led three studies testing GLP-1 drugs for PMOS, said the results are 'incredibly effective and really exciting,' with participants losing a median of about 42 pounds and experiencing a 52% testosterone drop.
- Charlotte Touzalin, an 18-year-old college student from Colorado, said she felt 'heard for the first time' after joining the study and became 'a happier version of myself,' though she stopped treatment in June when free access ended.
- Dr. Rana Malek, an endocrinologist with the University of Maryland Medical System, cautioned that GLP-1s don't work for everyone and can cause side effects like nausea; she said it's 'frustrating that many can't get them because of insurance issues.
Insights by Ground AI
47 Articles
47 Articles
Obesity drugs show early promise against the hormonal disorder PMOS, g
Charlotte Touzalin was still a young teenager when she began struggling with weight gain, abnormal periods and unwanted facial hair — the same puzzling symptoms that plagued her mom for decades and that no doctor could piece together. “I’d go home and I’d cry,” said Touzalin, an 18-year-old college student from Colorado. “I didn’t understand why all this weight was coming back or why my friends didn’t have to shave their faces and I had to.” Tou…
·Baltimore, United States
Read Full Article
Associated Press News+45 Reposted by 45 other sources
Obesity drugs show early promise against the hormonal disorder PMOS, giving a suffering family hope
A small but growing body of research shows that GLP-1 drugs often used to treat obesity may also work for the hormonal disorder known as PMOS.
·New York, United States
Read Full ArticleCoverage Details
Total News Sources47
Leaning Left17Leaning Right5Center23Last UpdatedBias Distribution51% Center
Bias Distribution
- 51% of the sources are Center
51% Center
L 38%
C 51%
11%
Factuality
To view factuality data please Upgrade to Premium
